A patent review of SHP2 allosteric inhibitors (2018-present)
{{output}}
Introduction: SHP2 (Src homology region 2-containing protein tyrosine phosphatase 2) is a target of interest for cancer therapy due to its key role in the regulation of the RAS/MAPK signal transduction pathway downstream of Recep... ...
